Advertisement

Topics

BeiGene Ltd. Company Profile

00:56 EDT 21st June 2018 | BioPortfolio

BeiGene is an innovative, clinical-stage Chinese oncology R&D company focused on discovering, developing and commercializing targeted and immune-oncology therapeutics through a novel translational research platform that leverages our strong internal oncology biology expertise with unique access to large number of patient-derived tumor biopsies. With a team of 150 scientists and staff, its pipeline is comprised of novel oral small molecules and monoclonal antibodies for cancer. BeiGene Ltd. is a Cayman Islands exempted company that is an investor in and collaborator with BeiGene (Beijing), Co. Ltd. For more information, please visit our website at www.beigene.com.


News Articles [82 Associated News Articles listed on BioPortfolio]

BeiGene Completes $750 Million Secondary Offering

BeiGene, a Beijing innovative cancer biotech, raised a spectacular $750 million in a secondary offering of its shares. The price of the shares ended the session 13% higher after the funding was announ...

Public ADS offering nets $710.6mm for BeiGene

BeiGene (Beijing) Co. Ltd. (immuno-oncology) netted $710.6mm through the public sale of 7.4mm American Depositary Shares (representing 96.5mm common) priced at $101 per ADS. Proceeds will support gene...

Public ADS offering nets $758mm for BeiGene

BeiGene (Beijing) Co. Ltd. (immuno-oncology) netted $758mm through the public sale of 7.9mm American Depositary Shares (representing 103mm common; including the overallotment) priced at $101 per ADS. ...

BeiGene, Boehringer Ingelheim Enter Supply Agreement

For tislelizumab, BeiGene’s investigational anti-PD-1 antibody

BeiGene Appoints Senior Pharmaceutical Executive Dr. Xiaobin Wu as General Manager of China and President of BeiGene, Ltd.

BEIJING, China and CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovativ...

Boehringer, BeiGene enter manufacturing pact for PD-1 drug

In a hookup with the German drugmaker, BeiGene gets a boost for tislelizumab production.

BeiGene in-licenses sitravatinib in the Asia Pacific Region

BeiGene has signed an exclusive license agreement for the development, manufacturing and commercialization…

BeiGene Launches Third Celgene Cancer Drug in China

Beijing's BeiGene has launched Vidaza® in China. Vidaza is a nucleoside metabolic inhibitor that is approved in China for patients with myelodysplastic syndrome (MDS), acute myeloid leukemia (AML)...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial

The purpose of this research study is to look at the effects, good or bad, of TetMYB Vaccine in combination with BGB-A317 in patients with advanced or metastatic solid cancers (including c...

Companies [4 Associated Companies listed on BioPortfolio]

BeiGene (Beijing), Co., Ltd.

BeiGene is an innovative Chinese oncology R&D company focusing on discovering, developing and commercializing targeted and immune-oncology therapeutics. With a team of 150 scienti...

BeiGene Ltd.

BeiGene is an innovative, clinical-stage Chinese oncology R&D company focused on discovering, developing and commercializing targeted and immune-oncology therapeutics through a no...

BeiGene, Ltd.

BeiGene is a Chinese life sciences biotechnology company based in the Zhongguancun Life Science Park in Beijing that is focused on discovering and developing innovative oncology d...

Celgene Corporation and BeiGene, Ltd.

More Information about "BeiGene Ltd." on BioPortfolio

We have published hundreds of BeiGene Ltd. news stories on BioPortfolio along with dozens of BeiGene Ltd. Clinical Trials and PubMed Articles about BeiGene Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BeiGene Ltd. Companies in our database. You can also find out about relevant BeiGene Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record